Filing Details

Accession Number:
0001438133-21-000226
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-01 19:59:13
Reporting Period:
2021-11-29
Accepted Time:
2021-12-01 19:59:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM Surgical & Medical Instruments & Apparatus (3841) 204327508
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866570 James Leal C/O Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego CA 92121
Svp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-29 310 $0.00 4,162 No 4 M Direct
Common Stock Disposition 2021-11-29 154 $129.66 4,008 No 4 F Direct
Common Stock Acquisiton 2021-11-29 1,667 $51.50 5,675 No 4 M Direct
Common Stock Acquisiton 2021-11-29 238 $82.34 5,913 No 4 M Direct
Common Stock Disposition 2021-11-29 1,236 $130.64 4,677 No 4 S Direct
Common Stock Disposition 2021-11-29 664 $131.54 4,013 No 4 S Direct
Common Stock Disposition 2021-11-29 5 $132.92 4,008 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Acquisiton 2021-11-29 310 $0.00 310 $0.00
Common Stock Stock Option Acquisiton 2021-11-29 1,667 $51.50 1,667 $51.50
Common Stock Stock Option Acquisiton 2021-11-29 238 $82.34 238 $82.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,097 No 4 M Direct
25,000 No 4 M Direct
7,148 No 4 M Direct
Footnotes
  1. Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
  2. Represents shares of common stock received upon exercise of a stock option award.
  3. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
  4. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $130.19 to $131.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  5. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $131.48 to $132.24.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  6. Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
  7. Each RSU represents a contingent right to receive one share of common stock of the Company.
  8. RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
  9. The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.
  10. The expiration date for these options is 10 years from the date of grant.
  11. The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.